Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153,298 | 104,139 | 585,578 | 99,957 | 78,228 |
| Marketable Securities | 125,283 | 184,512 | 70,831 | 421,705 | 213,722 |
| Receivables | 105,556 | 98,397 | 96,318 | 53,046 | 47,530 |
| Inventories | 104,353 | 96,063 | 98,550 | 64,650 | 58,296 |
| TOTAL | $509,994 | $498,334 | $866,048 | $651,623 | $408,557 |
| Non-Current Assets | |||||
| PPE Net | 173,927 | 183,512 | 188,401 | 136,688 | 104,681 |
| Investments And Advances | 2,410 | 37,209 | 0 | 95,459 | 75,769 |
| Intangibles | 646,501 | 703,789 | 769,143 | 196,068 | 203,934 |
| Other Non-Current Assets | 241,554 | 258,356 | 251,761 | 194,675 | 38,124 |
| TOTAL | $1,064,392 | $1,182,866 | $1,209,305 | $622,890 | $422,508 |
| Total Assets | $1,574,386 | $1,681,200 | $2,075,353 | $1,274,513 | $831,065 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 8,641 | 33,648 | 24,234 | N/A | N/A |
| Accounts payable and accrued liabilities | 15,698 | 15,220 | 10,543 | 10,431 | 12,799 |
| Accrued Expenses | 64,243 | 89,785 | 127,555 | 70,974 | 70,427 |
| Other current liabilities | N/A | N/A | N/A | 14,736 | 18,179 |
| TOTAL | $97,383 | $147,774 | $521,118 | $253,328 | $107,673 |
| Non-Current Liabilities | |||||
| Long Term Debt | 115,202 | 251,056 | 335,263 | N/A | N/A |
| Other Non-Current Liabilities | 491,671 | 507,360 | 488,564 | 401,497 | 368,448 |
| TOTAL | $606,873 | $758,416 | $823,827 | $401,497 | $368,448 |
| Total Liabilities | $704,256 | $906,190 | $1,344,945 | $654,825 | $476,121 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 46,501 | 45,952 | 44,848 | 43,863 | 42,033 |
| Common Shares | 46 | 46 | 45 | 44 | 42 |
| Retained earnings | -106,796 | -148,751 | -211,895 | -253,875 | -399,398 |
| Other shareholders' equity | 247 | -380 | 167 | 318 | 322 |
| TOTAL | $870,130 | $775,010 | $730,408 | $619,688 | $354,944 |
| Total Liabilities And Equity | $1,574,386 | $1,681,200 | $2,075,353 | $1,274,513 | $831,065 |